FHJUX
Price
$50.04
Change
+$0.27 (+0.54%)
Updated
Jun 2 closing price
Net Assets
987.58M
UEPIX
Price
$24.19
Change
-$0.16 (-0.66%)
Updated
Jun 3 closing price
Net Assets
6.82M
Interact to see
Advertisement

FHJUX vs UEPIX

Header iconFHJUX vs UEPIX Comparison
Open Charts FHJUX vs UEPIXBanner chart's image
FHJUX vs UEPIX Comparison Chart in %
View a ticker or compare two or three
VS
FHJUX vs. UEPIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHJUX is a Buy and UEPIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FHJUX has more cash in the bank: 988M vs. UEPIX (6.83M). FHJUX pays higher dividends than UEPIX: FHJUX (1.77) vs UEPIX (1.36). FHJUX was incepted earlier than UEPIX: FHJUX (12 years) vs UEPIX (27 years). UEPIX (2.53) is less costly to investors than FHJUX (1.07). UEPIX is a more actively managed with annual turnover of: 712.00 vs. FHJUX (51.00). FHJUX has a lower initial minimum investment than UEPIX: FHJUX (0) vs UEPIX (15000). UEPIX annual gain was more profitable for investors over the last year : 43.85 vs. FHJUX (18.52). UEPIX return over 5 years is better than : 85.40 vs. FHJUX (14.21).
FHJUXUEPIXFHJUX / UEPIX
Total Expense Ratio1.071.7860%
Annual Report Gross Expense Ratio1.072.5342%
Fund Existence12 years27 years-
Gain YTD7.15225.51528%
Front Load6%N/A-
Min. Initial Investment015000-
Min. Initial Investment IRAN/AN/A-
Net Assets988M6.83M14,476%
Annual Yield % from dividends1.771.36130%
Returns for 1 year18.5243.8542%
Returns for 3 years59.2389.9366%
Returns for 5 years14.2185.4017%
Returns for 10 years52.78168.0931%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMKBX18.05N/A
N/A
Morgan Stanley Inst Emerging Mkts A
RBCRX12.90N/A
N/A
RBC China Equity R6
DURPX29.76N/A
N/A
DFA US Hi Relatv Profitability Instl
FQTEX14.98N/A
N/A
Franklin Templeton SMACS: Series E Adv
DWOIX21.64-0.26
-1.19%
BNY Mellon Research Growth I